Health & Medicine
-
ERNA-101 Platform Targets Cancer with Differentiated Therapy
NEW YORK, July 15 — A new targeted cancer therapy platform is moving toward its first human trials, offering a potential advance…
-
Ernexa Plans IND Filing in Q3 and Ovarian Cancer Trial in Q4 2026
NEW YORK, July 15 — Ernexa Therapeutics is moving its lead candidate ERNA-101 toward a first-in-human Phase 1 study, with the trial…
-
Heavy Marijuana Use Linked to Nearly Four Times the Lung Cancer Risk in Large U.S. Study
WASHINGTON, July 15 — A senior epidemiologist at a major U.S. university or government agency is the lead researcher behind a new…
-
Bowel Cancer Five-Year Survival Falls From 91.5% at Early Stage to 16.2% at Stage 4
INDIANAPOLIS, July 15 — A study released yesterday by the Indiana University School of Medicine documents a stark divide in bowel cancer…
-
Ernexa Therapeutics Advances ERNA-101 to First-in-Human Trial Planning
SINGAPORE, July 15 — A new cancer therapy candidate is taking its first step from the laboratory bench toward the bedside, with…
-
Cannabis use disorder linked to nearly four times the lung cancer risk, study finds
WASHINGTON, July 15 — A major new study, described as the largest of its kind in the United States, has found that…
-
New Alzheimer’s Drug Kisunla Carries Significant Brain Risk Factors
The U.S. Food and Drug Administration approved Eli Lilly’s monoclonal antibody donanemab, marketed as Kisunla, on July 15, 2024. The drug is…
-
Akeso gets FDA and China clearance for Phase II cadonilimab liver cancer trial
BEIJING, July 15 — Akeso’s experimental cancer drug cadonilimab is now being studied in a Phase II clinical trial in the United…
-
Akeso starts US Phase II cadonilimab trial in gastric cancer with Memorial Sloan Kettering
ISLAMABAD, July 15 — Akeso, the Chinese biopharmaceutical company, has advanced its investigational drug cadonilimab into a Phase II clinical trial in…
-
Akeso Enrolls First Patient in Global Phase III Cadonilimab Trial for Gastric Cancer
SHANGHAI, July 15 — The figure that matters: 1.1 million new gastric cancer cases and 768,000 deaths each year, according to GLOBOCAN…
-
Pioneering pharmacologist honored for breast cancer breakthrough
WASHINGTON, July 15 — V. Craig Jordan, the British-American pharmacologist whose work turned tamoxifen into a cornerstone of hormone-positive breast cancer therapy,…
-
Tamoxifen and Uterine Cancer: What Gynecologists Advise for Women on the Breast Cancer Drug
WASHINGTON, July 15 — The U.S. Food and Drug Administration includes a boxed warning in tamoxifen’s prescribing information about the risk of…
-
How Tamoxifen Works: Blocking Estrogen Receptors in Breast Tissue
MANILA, July 15 — For women across the Philippines and the wider region facing hormone receptor-positive breast cancer, a medication called tamoxifen…
-
Glioblastoma: The Aggressive, Rare Brain Cancer With No Cure
LONDON, July 15 — For the roughly 12,000 people in the US and 3,200 people in the UK diagnosed with glioblastoma each…
-
Tamoxifen Has Treated Breast Cancer Since 1977, but Its Label Warns of Uterine Cancer
NEW YORK, July 15 — 1977. That is the year the U.S. Food and Drug Administration first approved tamoxifen. Nearly five decades…
-
Cannabis use disorder linked to nearly fourfold lung cancer risk in large U.S. study
WASHINGTON, July 15 — A large-scale U.S. study reported today shows a nearly four-times higher risk of lung cancer for heavy cannabis…
-
SHP2 Inhibitor Slowed RAS/MAPK-Driven Cancers in Lab Study, UCSF Team Reported
SAN DIEGO, July 15 — A molecular pathway that has frustrated cancer researchers for decades is finally giving up ground, one drug…
-
Schizophrenia caregivers spend $1,810 a month out of pocket, survey of 200 finds
LONDON, July 14 — The financial and emotional toll of caring for a brain cancer patient is severe, and data from the…
-
How Vaccines Train the Immune System and Cut Deaths from Disease
ASTANA, July 14 — The global vaccine market, a sector that directly shapes public health outcomes from Central Asia to the Americas,…
-
Scientist Unveils Twelve Key Mechanisms Behind Human Aging
OVIEDO, July 14 — Against this backdrop of accelerating longevity research, a Spanish biochemist whose work has fundamentally reshaped how scientists understand…
-
Sir John Hardy, Geneticist Behind Landmark Alzheimer’s Research, Honored with Top Science Prizes
LONDON, July 14 — The shift is this: one man’s hypothesis, now over three decades old, still drives the most promising treatments…
-
Rapamycin as a Longevity Drug: Strong Mouse Data, Early Human Evidence
NEW YORK, July 14 — A drug discovered on a remote Pacific island more than half a century ago is quietly reshaping…
-
Eisai and Biogen Rework Aducanumab Deal as Lecanemab Partnership Continues Unchanged
TOKYO, July 14 — Eisai Co., Ltd., the Japanese pharmaceutical firm with a history in neurology, finds its Alzheimer’s strategy at a…
-
Edward Jenner’s 1796 Smallpox Experiment: The Birth of Vaccination
LONDON, July 14 — Two hundred and thirty years ago this May, an English country doctor looked at the hands of a…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992
























